▪ Patient Treatment collabora- a machine Pharmaceutical ▪ Marketing Activities giving them much more o Patients with rare information before the tions with learning Companies ▪ Technological patients’ algorithm disease consult a medical Development practitioner. o Patient who wants to ▪ Pharmaceutical ✓ They helping the know information Support Support decentralized, Cambridge Judge customers treats and give real-time, accurate before consulting a Business School ▪ Personal data Security some description about decision making medical practitioner the rare disease. ✓ Treatment of patient with Key rare diseases in the Channels Various Resources emerging field of Organizations personalized medicine. o Company who ▪ Big Data Technology ✓ A ton of information that It is effectively to the wanted to cope to the ▪ Collaborative Ecosystem they gave is one of the good products. market needs with new rule of National ▪ Pharma Companies Health-Care ✓ Their technology could emerging Health Service of ▪ Various organization Providers about within global life help companies predict technologies because United Kingdom. such failures with high it can more gain sciences and health care o Health-Care accuracy, potentially ▪ Asset Sharing customers on your Providers saving millions of pounds ▪ Personalization a year industry
Cost Structure Revenue Streams Treatment of rare disease
Physical Cost Of Raw Companies Generated Partnership To Various
that charged Organizations Within Manufacturing Product Cost Material Used in Revenue Global Life Sciences and astronomical from Health Care to Efficiently Facilities Manufacturing prices Matches Treatments to Customers Rare Disease Patients.